FDA Introduces New Platform Technology Designation Guidance
FDA has taken a landmark step to streamline the drug application process for biotechnology companies by issuing new guidance on platform technology designation. This initiative…
Our blog
Latest news from our blog
Power of Pharmacogenomics in Personalizing Treatments
Emerging at the intersection of pharmacology and genomics, Pharmacogenomics (PGx) is an exciting field that aims to understand how an individual’s genetic makeup affects their…
Parallel Bio Brings Revolutionary “Clinical Trial in a Dish” to Accelerate Drug Discovery
Drug discovery and development is a very strenuous process that takes a lot of time and financial efforts. A drug takes over 10 years and…
The Way Forward for AI in Clinical Trials
Artificial intelligence has created a major disruption in all industries across the world. Particularly, AI in clinical trials has become a boon for the healthcare…
Innovative Use Cases of AI/ML in Clinical Trials
AI/ML technologies are playing an increasingly critical role in the domain of clinical trials. The success rate of trials is generally less than 10% but…
Artificial Intelligence in Pharmacovigilance: Enhancing Drug Safety
Organizations in the life sciences industry cannot turn a blind eye on the safety and integrity of investigational drugs in clinical research. That is exactly…
Bioequivalence in Clinical Trials: Explained
Developing new medical interventions is always a complicated affair for life sciences companies. For one thing – conducting clinical trials involves a whole lot of…
Moderna Harnessing the Power of AI for Drug Development
In what can be termed as a step towards innovation, pharmaceutical giant Moderna and OpenAI are joining hands to enhance the former’s workforce productivity by…
Innovating Healthcare: New FDA Approvals in 2024
In the clinical research industry, every year brings forth remarkable advancements and breakthroughs. FDA plays a pivotal role in approving innovative treatments that offer hope…
